Sean Smith, chief executive of Eden Research PLC (LON:EDEN), caught up with Proactive's Andrew Scott following the announcement their commercial partner, Eastman Chemical Company, has received a 120-day "emergency use" authorisation from the Italian Ministry of Agriculture for Eden's nematicide formulation - Cedroz.
Smith says during this period, Italy and other member states will continue to process Eastman's request for the authorised use and sale of Cedroz following earlier authorisation by Malta.